ASBrS Symposium 2024 | April 12 7:30-9:30 PM

Integrating genetic testing insights to optimize surgical decision making and personalize high-risk management

This session will educate the audience on how to incorporate genetic and genomic testing insights into clinical practice in order to guide personalized and preventative care and optimize surgical decision making for patients.

ASBrS Symposium 2024


Dr. David Weintritt, MD, FACS

Breast Cancer Surgeon at Virginia Cancer Specialists

Laura Brzeskiewicz, MS, CGC

Manager, Medical Science Liaisons at Myriad Genetics

Join us for this program by filling out the form below

April 12, 2024


Integrating genetic testing insights to optimize surgical decision-making and personalize high-risk management

Myriad needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time by using the unsubscribe link or instructions in any email communications we send. For further information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, please review our Privacy Policy.

Hidden Fields